{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:49:13Z","timestamp":1759942153215,"version":"3.32.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,11,26]],"date-time":"2005-11-26T00:00:00Z","timestamp":1132963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10067-005-0110-4","type":"journal-article","created":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T16:17:50Z","timestamp":1132935470000},"page":"532-536","source":"Crossref","is-referenced-by-count":38,"title":["C1q complement component and -antibodies reflect SLE activity and kidney involvement"],"prefix":"10.1007","volume":"25","author":[{"given":"P.","family":"Hor\u00e1k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"He\u0159manov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zadra\u017eil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cifersk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ordeltov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kus\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u017durek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tich\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,26]]},"reference":[{"key":"110_CR1","first-page":"345","volume":"8","author":"M Herrmann","year":"2000","unstructured":"Herrmann M, Voll RE, Lolowos W et al (2000) Pathogenesis of systemic lupus erythematosus. Immunologist 8:345\u2013350","journal-title":"Immunologist"},{"issue":"Suppl 3","key":"110_CR2","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","volume":"4","author":"MJ Walport","year":"2002","unstructured":"Walport MJ (2002) Complement and systemic lupus erythematosus. Arthritis Res 4[Suppl 3]:S279\u2013S293","journal-title":"Arthritis Res"},{"key":"110_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1078\/0171-2985-00141","volume":"205","author":"M Botto","year":"2002","unstructured":"Botto M, Walport MJ (2002) C1q, autoimmunity and apoptosis. Immunobiology 205:395\u2013406","journal-title":"Immunobiology"},{"key":"110_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.61.6.563","volume":"61","author":"D Monova","year":"2002","unstructured":"Monova D, Monov S, Rosenova K et al (2002) Autoantibodies against C1q: view on association between systemic lupus erythematosus disease manifestation and C1q autoantibodies. Ann Rheum Dis 61:563\u2013564","journal-title":"Ann Rheum Dis"},{"key":"110_CR5","unstructured":"Pickering MC, Walport MJ (2003) The complement system. In: Hochberg MC, Silman AJ, Smolen JS (eds) Rheumatology. 3rd edn, Mosby, pp 1323\u20131336"},{"key":"110_CR6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"110_CR7","first-page":"549","volume":"10","author":"W Bencivelli","year":"1992","unstructured":"Bencivelli W, Vitali C, Isenberg DA et al and the European Consensus Study Group for Disease Activity in SLE (1992) Disease activity in systemic lupus erythematosus: Report of the consensus study group of the European workshop for rheumatology research. III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 10:549\u2013554","journal-title":"Clin Exp Rheumatol"},{"key":"110_CR8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB et al. and The comittee on prognosis studies in SLE: Derivation of SLEDAI (1992) Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"110_CR9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/17.12.2041","volume":"17","author":"V Fremeaux-Bacchi","year":"2002","unstructured":"Fremeaux-Bacchi V, Noel LH, Schifferli JA (2002) No lupus nephritis in the absence of anti-C1q autoantibodies? Nephrol Dial Transplant 17:2041\u20132043","journal-title":"Nephrol Dial Transplant"},{"key":"110_CR10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1191\/096120399680411335","volume":"8","author":"DD Gladman","year":"1999","unstructured":"Gladman DD, Urowitz MB (1999) The SLICC\/ACR damage index: progress report and experience in the field. Lupus 8:632\u2013637","journal-title":"Lupus"},{"key":"110_CR11","first-page":"667","volume":"19","author":"L Horvath","year":"2001","unstructured":"Horvath L, Czirjak L, Fekete B et al. (2001) High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 19:667\u2013672","journal-title":"Clin Exp Rheumatol"},{"key":"110_CR12","first-page":"69","volume":"12","author":"P Hor\u00e1k","year":"2004","unstructured":"Hor\u00e1k P, Hermanov\u00e1 Z, Ordeltov\u00e1 J et al (2004) C1q complement component and apoptotic indices of B and T lymphocytes in the group of patients with systemic lupus erythematosus. Ces revmatol 12:69\u201375 (Czech)","journal-title":"Ces revmatol"},{"key":"110_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0162-3109(99)00018-1","volume":"42","author":"JS Navratil","year":"1999","unstructured":"Navratil JS, Korb LC, Ahearn JM (1999) Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42:47\u201352","journal-title":"Immunopharmacology"},{"key":"110_CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s003930070077","volume":"59","author":"M Trendelenburg","year":"2000","unstructured":"Trendelenburg M, Schifferli JA (2000) Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus. Z Rheumatol 59:172\u2013175 (German)","journal-title":"Z Rheumatol"},{"key":"110_CR15","first-page":"190","volume":"10","author":"A Kumar","year":"1999","unstructured":"Kumar A, Gupta R, Varghese T et al (1999) Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian J Med Res 10:190\u2013193","journal-title":"Indian J Med Res"},{"key":"110_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10067-003-0724-3","volume":"22","author":"P Oelzner","year":"2003","unstructured":"Oelzner P, Deliyska B, Funfstuck R, Hein G, Herrmann D, Stein G (2003) Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus \u2014 relationship with disease activity and renal involvement. Clin Rheumatol 22:271\u2013278","journal-title":"Clin Rheumatol"},{"key":"110_CR17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/anr.1780320910","volume":"32","author":"JJ Wisnieski","year":"1989","unstructured":"Wisnieski JJ, Naff GB (1989) Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 32:1119\u20131127","journal-title":"Arthritis Rheum"},{"key":"110_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0171-2985(98)80034-X","volume":"199","author":"CE Siegert","year":"1998","unstructured":"Siegert CE, Daha MR (1998) C1q as antigen in humoral autoimmune responses. Immunobiology 199:295\u2013302","journal-title":"Immunobiology"},{"key":"110_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0171-2985(98)80032-6","volume":"199","author":"MJ Walport","year":"1998","unstructured":"Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265\u2013285","journal-title":"Immunobiology"},{"key":"110_CR20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0003-4967(24)43394-3","volume":"80","author":"B Berner","year":"2001","unstructured":"Berner B, Scheel AK, Schettler V et al (2001) Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis 80:898\u2013899","journal-title":"Ann Rheum Dis"},{"key":"110_CR21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/1529-0131(200108)44:8<1962::AID-ART335>3.0.CO;2-R","volume":"44","author":"B Pfueller","year":"2001","unstructured":"Pfueller B, Wolbart K, Bruns A et al (2001) Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum 44:1962\u20131963","journal-title":"Arthritis Rheum"},{"key":"110_CR22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2133.2000.03369.x","volume":"142","author":"NM Stone","year":"2000","unstructured":"Stone NM, Williams A, Wilkinson JD et al (2000): Systemic lupus erythematosus with C1q deficiency. Br J Dermatol 142:521\u2013524","journal-title":"Br J Dermatol"},{"key":"110_CR23","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","volume":"158","author":"LC Korb","year":"1997","unstructured":"Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525\u20134528","journal-title":"J Immunol"},{"key":"110_CR24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","volume":"76","author":"MC Pickering","year":"2000","unstructured":"Pickering MC, Botto M, Taylor PR et al (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227\u2013234","journal-title":"Adv Immunol"},{"key":"110_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004310050567","volume":"156","author":"AL Berkel","year":"1997","unstructured":"Berkel AL, Petry F, Sanal O et al (1997) Development of systemic lupus erythematosus in a patient with selective complement C1q deficiency. Eur J Pediatr 156:113\u2013115","journal-title":"Eur J Pediatr"},{"key":"110_CR26","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.4049\/jimmunol.168.5.2538","volume":"168","author":"DA Mitchell","year":"2002","unstructured":"Mitchell DA, Pickering MC, Warren J et al (2002) C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168:2538\u20132543","journal-title":"J Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0110-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0110-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T22:58:01Z","timestamp":1736117881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0110-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,26]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0110-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2005,11,26]]}}}